Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Philip Zeitler to Mass Screening

This is a "connection" page, showing publications Philip Zeitler has written about Mass Screening.

 
Connection Strength
 
 
 
0.699
 
  1. Zeitler P, Pinhas-Hamiel O. Prevention and screening for type 2 diabetes in youth. Endocr Res. 2008; 33(1-2):73-91.
    View in: PubMed
    Score: 0.157
  2. Maniatis AK, Taylor L, Letson GW, Bloch CA, Kappy MS, Zeitler P. Congenital hypothyroidism and the second newborn metabolic screening in Colorado, USA. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):31-8.
    View in: PubMed
    Score: 0.136
  3. Love-Osborne K, Ringwood H, Sheeder J, Zeitler P. Quality improvement efforts in a safety net institution: Increased diabetes screening is associated with lower HbA1c at diagnosis and improved HbA1c outcomes in youth with type 2 diabetes. Pediatr Diabetes. 2022 12; 23(8):1579-1585.
    View in: PubMed
    Score: 0.110
  4. Chan CL, Hope E, Thurston J, Vigers T, Pyle L, Zeitler PS, Nadeau KJ. Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis. Diabetes Care. 2018 07; 41(7):1406-1413.
    View in: PubMed
    Score: 0.080
  5. Chan CL, McFann K, Newnes L, Nadeau KJ, Zeitler PS, Kelsey M. Hemoglobin A1c assay variations and implications for diabetes screening in obese youth. Pediatr Diabetes. 2014 Dec; 15(8):557-63.
    View in: PubMed
    Score: 0.060
  6. Zeitler P. Update on nonautoimmune diabetes in children. J Clin Endocrinol Metab. 2009 Jul; 94(7):2215-20.
    View in: PubMed
    Score: 0.043
  7. Love-Osborne K, Butler N, Gao D, Zeitler P. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes. Pediatr Diabetes. 2006 Aug; 7(4):205-10.
    View in: PubMed
    Score: 0.036
  8. Steelman J, Zeitler P. Osteoporosis in pediatrics. Pediatr Rev. 2001 Feb; 22(2):56-65.
    View in: PubMed
    Score: 0.024
  9. Tommerdahl KL, Brinton JT, Vigers T, Nadeau KJ, Zeitler PS, Chan CL. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c. Pediatr Diabetes. 2019 12; 20(8):1080-1086.
    View in: PubMed
    Score: 0.022
  10. Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin. Pediatr Diabetes. 2016 May; 17(3):206-11.
    View in: PubMed
    Score: 0.016
  11. Love-Osborne KA, Sheeder J, Svircev A, Chan C, Zeitler P, Nadeau KJ. Use of glycosylated hemoglobin increases diabetes screening for at-risk adolescents in primary care settings. Pediatr Diabetes. 2013 Nov; 14(7):512-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)